Photodynamic Therapy News and Research

RSS
Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International

Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International

Polypoidal choroidal vasculopathy shows distinct classification

Polypoidal choroidal vasculopathy shows distinct classification

RPCI receives NCI grant to continue research program on photodynamic therapy for head and neck cancers

RPCI receives NCI grant to continue research program on photodynamic therapy for head and neck cancers

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

University of York scientists use low temperature plasmas to treat prostate cancer

University of York scientists use low temperature plasmas to treat prostate cancer

Scientists develop new type of carrier that combines photosensitivity and magnetism to fight cancer

Scientists develop new type of carrier that combines photosensitivity and magnetism to fight cancer

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

Concordia Healthcare reports record revenues of 147% in third quarter 2014

Concordia Healthcare reports record revenues of 147% in third quarter 2014

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics